IVP - Health AI 35: What to know, who to watch - September 2024
FreeGenerative AI's potential to revolutionize healthcare
FreeFree tier
About IVP - Health AI 35: What to know, who to watch - September 2024
A report from venture capital firm IVP (International Venture Partners) that identifies and analyzes 35 health AI companies creating value for patients, providers, pharmaceutical companies, and payers. The report categorizes companies into areas such as patient trust and care, AI-enabled medical devices, academic search engines, AI-native agents and coaches, and provider workflow automation. It includes insights on market dynamics, investment themes, and notable startups like Hello Heart, Consensus, Abridge, and WHOOP.
Key Features
Curated list of 35 health AI companies across patient, provider, and payer segments
Insights on AI-enabled medical devices, academic search engines, and AI-native coaches
Analysis of workflow automation opportunities for healthcare providers
Focus on companies with technological advantage and unique go-to-market strategies
Includes IVP portfolio companies like Hello Heart, Abridge, WHOOP
Pros & Cons
Pros
- Comprehensive overview of leading health AI companies across multiple verticals
- Insights from experienced VC firm with deep healthcare focus
- Highlights real-world adoption by practitioners
- Covers both patient-facing and provider-facing AI solutions
Cons
- Not a software tool but a research report; actionable implementation details limited
- Focuses on US market and IVP portfolio may skew selection
- Report is from September 2024, may not reflect latest developments
Best For
Investors evaluating health AI opportunitiesHealthcare executives exploring AI adoptionEntrepreneurs seeking market intelligence in digital healthResearchers tracking AI trends in medicineProviders looking to reduce administrative burden with AI
FAQ
What is the Health AI 35 report?
It is a report published by IVP in September 2024 that highlights 35 health AI companies creating value for patients, providers, pharmaceutical companies, and payers.
Who is the target audience for this report?
The report is aimed at investors, healthcare professionals, entrepreneurs, and anyone interested in the impact of generative AI on healthcare.
What types of companies are featured?
Companies span AI-enabled medical devices, academic search engines, AI-native agents and coaches, workflow automation for providers, and more.
Is this a free resource?
Yes, the report is publicly available on IVP's website without charge.